AİFD: 2008 for the pharmaceutical sector

ISTANBUL (UAV) - Researchers Pharmaceutical Companies Association (AİFD), 2008 an important year for Turkey in the pharmaceutical sector will be made.

AİFD'den made in 2008 on health reform, improve the investment environment and the sector on measures to improve the global competitiveness should be pointed out that serious progress has been.

In 2008 the pharmaceutical sector in Turkey will be an important recording AİFD, Turkey's innovative drug research, development and production as a global power, in other countries of the developed technology and products among the audience of a way to stay in the said separation.

AİFD in 2008 to discover new drugs and to investigate global-scale investment of nearly 70 billion dollars to do that and call for the trial stage of cancer in more than 600 new medicines to the island, more than 6 thousand of new drug candidates under development said.

New production centers, equipment and renovation will be done this year for the investment of billions of dollars is added in 2008 in the innovative pharmaceutical industry about $ 100 billion at the global level, in the amount of investment is expected to be made.

Issues related to evaluating the Secretary-General AİFD Engin Güner, "Turkey in 2008 in the innovative pharmaceutical sector to competition and health sciences in the global investment rather than a greater share of opportunities to catch. However, this decision of a global race and that Turkey's successful compete for the right vision, strategy and policies should be implemented must be able to see a clear way, "he said.

"Turkey for new drugs in 2007 for 1 percent of global investments attract a lower rate than the very advanced stages of clinical research in the direction of funds to the approximately 27 million dollars, only able to receive" says Engin Guner, "from Turkey in total exports of generic and innovative pharmaceutical 350 million the dollar was lower. Turkey's much smaller than Ireland and that of countries like Singapore drug exports billions of dollars to overcome. Ireland's pharmaceutical export chemicals with 50 billion dollars to overcome. This country's domestic drug consumption financing exports rapidly growing support from drug production tax from the to provide, "he spoke.

"2008, a critical year of decision"
Guner, "AİFD, Turkey, Health Sciences is a competitor in the global position as the past 2 years many proposals were submitted. The future to keep things light with innovative medicines and health sciences industry to develop the potential for many constructive activities, and have offered suggestions. Ülkemizin truly first-class quality to have in an innovative pharmaceutical industry is our most important priorities at this stage "as it had not.

Secretary General Engin Güner AİFD sector can reach a more advanced point in the following order of priority objectives are:
"New drugs are licensed from 2-3 years and be paid back in 6-9 months to licensing reform,
Accelerate the process of harmonization with EU standards, waiting a long time, clinical research for the realization of legal arrangements to raise standards, tax incentives,
To attract international investment in Turkey, to investigate innovative drugs, the leading country in production and exports among other measures to ensure access. "

"In Singapore, if a new drug known worldwide, such as FDA and EMEA approval of the organization has received as little as 2 months at a time to be produced and marketed for licenses in Turkey, this time in 2 years can take up to" said the new production Güner evaluate decisions in terms of the company, 2 months and 2 years was the difference between the points to the importance of.

Turkey yaşadığı's brain drain problem attracts the attention Güner, "Our country medicine and science in the field of rich human resources has. But support policies because of the lack of these people, research and development efforts in large part to do abroad. Turkey in more R & D investments to encourage there is a need for new policies, "he said.

In Turkey, the innovative pharmaceutical industry and life sciences in terms of the assessment in 2007 that Güner, "the good way of work in 2007 of the proposed decision to listen more carefully to be started, and Turkey, a world class competitors are seeing could be. However, the investment environment to improve a little more concrete step did not. Yet the world pharmaceutical industry experienced a serious competition does. innovative pharmaceutical industry, Ireland, Singapore, China or India in the ongoing new investments are made. We in our country for the pharmaceutical sector road map for establishing as always, will contribute. our government to us, a critical decision The correct year 2008 and long-term policies to put into practice hope. Ireland or Singapore as models of innovative medicines covered by evaluating and implementing the right policies, Turkey innovative drugs in the new investments may be about 1 billion dollars, "he spoke.